Stocks and Investing Stocks and Investing
Wed, April 24, 2013
Tue, April 23, 2013
Mon, April 22, 2013
Fri, April 19, 2013
Thu, April 18, 2013
Wed, April 17, 2013

Andrew Peters Maintained (BIIB) at Strong Buy with Increased Target to $240 on, Apr 22nd, 2013


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-240-on-apr-22nd-2013.html
Published in Stocks and Investing on Friday, October 25th 2024 at 2:29 GMT by   Print publication without navigation


Andrew Peters of Deutsche Bank, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $170 to $240 on, Apr 22nd, 2013.

Andrew has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $141 on, Thursday, January 3rd, 2013
  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $166 on, Thursday, January 3rd, 2013


These are the ratings of the 4 analyists that currently disagree with Andrew


  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $215 on, Tuesday, April 9th, 2013
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $225 on, Thursday, April 4th, 2013
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $206 on, Monday, April 1st, 2013
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $188 on, Monday, March 25th, 2013

Similar Stocks and Investing Publications